… oncogenic activation of the mutated BRAF kinase (33, 43). A few other … BRAF mutants are
only rarely found in thyroid cancer, such as the BRAF K601E (44), AKAP9-BRAF (45), BRAF …

… Papillary thyroid cancer (PTC) is a common endocrine malignancy that frequently harbors
the oncogenic T1799A BRAF mutation. As a novel prognostic molecular marker, this mutation …

… neck cancers but not in bladder, cervical, or prostate cancers. Our data suggest that activating
BRAF mutations may be an important event in the development of papillary thyroid cancer. …

… BRAF V600E–negative and BRAF V600E–positive groups for all patients and for patients with
conventional papillary thyroid cancer (PTC… of the Interaction of BRAF V600E Mutation With …

… the most rapidly increasing cancer among women and the … thyroid cancers are classified
into papillary thyroid cancer (PTC), follicular thyroid cancer (FTC), and anaplastic thyroid cancer …

… Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph
node metastasis reveals a new mutation in metastasis. Clinical Endocrinology 62 509–511. …

… Joint Committee on Cancer staging system. Genomic … BRAF gene to identify BRAF V600E
mutation, as described in our previously published studies. In all cases, BRAF V600E mutation …

… shown that this BRAF mutation occurs in papillary thyroid cancer (PTC) … BRAF mutation
occurs exclusively in PTC and PTC-derived anaplastic thyroid cancers but not in normal thyroid …

… The hot-spot mutation BRAF V599E is frequently detected in PTC (36–… thyroid lesions. In
order to unravel whether there is any association between the occurrence of the BRAF mutation …

… section of thyroid tumor. We analyzed the prevalence of the BRAF V600E mutation and …
Data regarding age at diagnosis, gender, tumor size, multifocality, extrathyroidal extension, …